Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BVS Bioventus	$6.62 -1.3%	$7.03	$5.28 ▼ $14.38	$543.79M	0.86	455,363 shs	255,302 shs
DCTH Delcath Systems	$15.34 -1.9%	$14.07	$7.17 ▼ $18.23	$534.23M	0.95	388,644 shs	316,414 shs
GUTS Fractyl Health	$2.06 -5.1%	$1.61	$0.87 ▼ $5.74	$100.89M	1.85	327,579 shs	290,851 shs
KIDS OrthoPediatrics	$21.16 -2.6%	$21.51	$19.52 ▼ $35.99	$513.91M	1.08	200,600 shs	108,387 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BVS Bioventus	-1.34%	-1.05%	+3.76%	-31.11%	-2.36%
DCTH Delcath Systems	-1.92%	-6.35%	-0.84%	+21.94%	+113.95%
GUTS Fractyl Health	-5.07%	+3.52%	+34.20%	+60.94%	-66.23%
KIDS OrthoPediatrics	-2.58%	-0.14%	-7.40%	-15.63%	-32.74%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BVS Bioventus	3.36 of 5 stars	3.3	0.0	0.0	2.7	4.2	1.3
DCTH Delcath Systems	3.5755 of 5 stars	3.5	5.0	0.0	3.2	2.5	0.6
GUTS Fractyl Health	2.3693 of 5 stars	3.5	2.0	0.0	3.8	1.7	0.0
KIDS OrthoPediatrics	4.2564 of 5 stars	3.4	2.0	3.9	2.1	4.2	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BVS Bioventus	2.67	Moderate Buy	$14.33	116.52% Upside
DCTH Delcath Systems	3.00	Buy	$24.00	56.45% Upside
GUTS Fractyl Health	3.00	Buy	$11.00	433.98% Upside
KIDS OrthoPediatrics	2.83	Moderate Buy	$35.83	69.34% Upside

Current Analyst Ratings Breakdown

Latest GUTS, DCTH, BVS, and KIDS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/23/2025	DCTH Delcath Systems	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$24.00 ➝ $29.00
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00
5/8/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
5/7/2025	BVS Bioventus	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$15.00
4/15/2025	GUTS Fractyl Health	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$12.00
4/11/2025	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$26.00 ➝ $24.00
4/9/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/7/2025	KIDS OrthoPediatrics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$37.00
3/17/2025	BVS Bioventus	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$15.00 ➝ $15.00

(Data available from 6/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BVS Bioventus	$567.70M	0.96	$0.53 per share	12.58	$2.80 per share	2.36
DCTH Delcath Systems	$53.85M	9.92	N/A	N/A	$0.72 per share	21.31
GUTS Fractyl Health	$60K	1,681.54	N/A	N/A	N/A	∞
KIDS OrthoPediatrics	$212.45M	2.42	N/A	N/A	$16.14 per share	1.31

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BVS Bioventus	-$156.23M	-$0.48	N/A	14.39	N/A	-7.11%	15.61%	4.01%	N/A
DCTH Delcath Systems	-$47.68M	-$0.50	N/A	N/A	N/A	-150.70%	-338.16%	-104.02%	8/4/2025 (Estimated)
GUTS Fractyl Health	-$77.09M	-$1.85	N/A	N/A	N/A	-64,849.48%	N/A	-57.21%	8/13/2025 (Estimated)
KIDS OrthoPediatrics	-$20.97M	-$1.75	N/A	N/A	N/A	-15.00%	-5.78%	-4.80%	8/4/2025 (Estimated)

Latest GUTS, DCTH, BVS, and KIDS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/13/2025	Q1 2025	GUTS Fractyl Health	-$0.49	-$0.49	N/A	-$0.49	N/A	N/A
5/8/2025	Q1 2025	DCTH Delcath Systems	$0.10	$0.03	-$0.07	$0.03	$16.83 million	$19.80 million
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BVS Bioventus	N/A	N/A	N/A	N/A	N/A
DCTH Delcath Systems	N/A	N/A	N/A	N/A	N/A
GUTS Fractyl Health	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BVS Bioventus	1.85	1.41	0.99
DCTH Delcath Systems	N/A	1.34	1.03
GUTS Fractyl Health	0.60	5.58	5.57
KIDS OrthoPediatrics	0.19	7.17	3.68

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BVS Bioventus	62.94%
DCTH Delcath Systems	61.12%
GUTS Fractyl Health	N/A
KIDS OrthoPediatrics	69.05%

Insider Ownership

Company	Insider Ownership
BVS Bioventus	33.00%
DCTH Delcath Systems	17.40%
GUTS Fractyl Health	N/A
KIDS OrthoPediatrics	32.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BVS Bioventus	1,200	82.14 million	54.46 million	Not Optionable
DCTH Delcath Systems	60	34.83 million	26.24 million	Optionable
GUTS Fractyl Health	102	48.98 million	N/A	N/A
KIDS OrthoPediatrics	200	24.29 million	16.52 million	Optionable

GUTS, DCTH, BVS, and KIDS Headlines

Recent News About These Companies

Harbor Capital Advisors Inc. Has $3.80 Million Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

June 11 at 5:26 AM | marketbeat.com

OrthoPediatrics (NASDAQ:KIDS) Lowered to Sell Rating by Wall Street Zen

June 9, 2025 | americanbankingnews.com

OrthoPediatrics (NASDAQ:KIDS) Downgraded by Wall Street Zen to "Sell"

June 7, 2025 | marketbeat.com

Analysts Set OrthoPediatrics Corp. (NASDAQ:KIDS) Target Price at $35.83

June 5, 2025 | americanbankingnews.com

OrthoPediatrics (NASDAQ:KIDS) Hits New 12-Month Low - Here's Why

June 4, 2025 | marketbeat.com

Bank of America Corp DE Has $1.85 Million Stock Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

June 4, 2025 | marketbeat.com

OrthoPediatrics Corp. (NASDAQ:KIDS) Receives Consensus Rating of "Moderate Buy" from Brokerages

June 2, 2025 | marketbeat.com

OrthoPediatrics Corp. (NASDAQ:KIDS) Shares Purchased by Wellington Management Group LLP

June 1, 2025 | marketbeat.com

422,705 Shares in OrthoPediatrics Corp. (NASDAQ:KIDS) Purchased by Millennium Management LLC

May 26, 2025 | marketbeat.com

AWM Investment Company Inc. Boosts Stock Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

May 23, 2025 | marketbeat.com

Paradigm Capital Management Inc. NY Reduces Stock Holdings in OrthoPediatrics Corp. (NASDAQ:KIDS)

May 22, 2025 | marketbeat.com

321,405 Shares in OrthoPediatrics Corp. (NASDAQ:KIDS) Bought by Point72 Asset Management L.P.

May 22, 2025 | marketbeat.com

Cubist Systematic Strategies LLC Buys Shares of 19,903 OrthoPediatrics Corp. (NASDAQ:KIDS)

May 19, 2025 | marketbeat.com

16,061 Shares in OrthoPediatrics Corp. (NASDAQ:KIDS) Acquired by Numerai GP LLC

May 18, 2025 | marketbeat.com

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 13,270 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS)

May 16, 2025 | marketbeat.com

OrthoPediatrics amends acquisition agreement terms

May 15, 2025 | uk.investing.com

GRAMMYÂ® AWARD-WINNING, MULTIPLATINUM GLOBAL SUPERSTAR TYLA TO HOST NICKELODEON KIDS' CHOICE AWARDS 2025--THE BIGGEST PARTY OF THE SUMMER --LIVE ON SATURDAY, JUNE 21, AT 8 P.M. (ET/PT)

May 15, 2025 | prnewswire.com

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting

May 14, 2025 | gurufocus.com

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting

May 14, 2025 | globenewswire.com

OrthoPediatrics Corp. (KIDS) Q1 2025 Earnings Call Transcript

May 11, 2025 | seekingalpha.com

OrthoPediatrics grows 1st quarter revenue

May 9, 2025 | beckersspine.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

GUTS, DCTH, BVS, and KIDS Company Descriptions

Bioventus NYSE:BVS

$6.62 -0.09 (-1.34%)

Closing price 06/13/2025 04:00 PM Eastern

Extended Trading

$6.62 0.00 (0.00%)

As of 06/13/2025 04:18 PM Eastern

Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Delcath Systems NASDAQ:DCTH

$15.34 -0.30 (-1.92%)

Closing price 06/13/2025 04:00 PM Eastern

Extended Trading

$15.49 +0.15 (+0.98%)

As of 06/13/2025 06:45 PM Eastern

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

Fractyl Health NASDAQ:GUTS

$2.06 -0.11 (-5.07%)

Closing price 06/13/2025 04:00 PM Eastern

Extended Trading

$2.11 +0.05 (+2.43%)

As of 06/13/2025 07:54 PM Eastern

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

OrthoPediatrics NASDAQ:KIDS

$21.16 -0.56 (-2.58%)

Closing price 06/13/2025 04:00 PM Eastern

Extended Trading

$21.16 0.00 (-0.02%)

As of 06/13/2025 04:04 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time